Is AKBLF or RYLD a better dividend investment in 2026?

AKBLF currently yields 0.80% with a 5% 5-year dividend growth rate. RYLD yields 12.14% with 5% growth. The better choice depends on your goal: RYLD offers higher current income.

What is the dividend yield difference between AKBLF and RYLD?

AKBLF has a forward dividend yield of 0.80% ($0.25/share annually). RYLD yields 12.14% ($1.81/share annually). The yield gap is 11.34 percentage points.

Home › Compare › AKBLF vs RYLD

AKBLF vs RYLD: Dividend Comparison 2026

AKBLF yields 0.80% · RYLD yields 12.14%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 RYLD wins by $23.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

AKBLF

● Live price

0.80%

Share price

$31.35

Annual div

$0.25

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.8K

Annual income

$83.98

Full AKBLF calculator →

RYLD

● Live price

12.14%

Share price

$14.95

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.5K

Annual income

$2,587.35

Full RYLD calculator →

Portfolio growth — AKBLF vs RYLD

📍 RYLD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AKBLF	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AKBLF + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AKBLF pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AKBLF

Annual income on $10K today (after 15% tax)

$67.78/yr

After 10yr DRIP, annual income (after tax)

$71.38/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,031.60/yr

After 10yr DRIP, annual income (after tax)

$2,199.25/yr

At 15% tax rate, RYLD beats the other by $2,127.86/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AKBLF + RYLD for your $10,000?

AKBLF: 50%RYLD: 50%

100% RYLD50/50100% AKBLF

Portfolio after 10yr

$32.7K

Annual income

$1,335.66/yr

Blended yield

4.09%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on AKBLF right now

AKBLF

Analyst Ratings

Buy

Consensus: Buy

Altman Z

11.6

Piotroski

8/9

RYLD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AKBLF buys

RYLD buys

No recent congressional trades found for AKBLF or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAKBLFRYLD

Forward yield	0.80%	12.14% ✓
Annual dividend / share	$0.25	$1.81 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$20.8K	$44.5K ✓
Annual income after 10y	$83.98	$2,587.35 ✓
Total dividends collected	$820.00 ✓	$18.8K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: AKBLF vs RYLD ($10,000, DRIP)

Year	AKBLF Portfolio	AKBLF Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$10,780	$79.74	$11,914	$1,213.65	$1.1K → RYLD
2	$11,615	$80.34	$14,099	$1,351.30	$2.5K → RYLD
3	$12,509	$80.90	$16,580	$1,494.55	$4.1K → RYLD
4	$13,466	$81.43	$19,384	$1,642.61	$5.9K → RYLD
5	$14,490	$81.92	$22,535	$1,794.70	$8.0K → RYLD
6	$15,587	$82.39	$26,063	$1,950.00	$10.5K → RYLD
7	$16,761	$82.82	$29,995	$2,107.69	$13.2K → RYLD
8	$18,017	$83.24	$34,361	$2,266.99	$16.3K → RYLD
9	$19,362	$83.62	$39,194	$2,427.12	$19.8K → RYLD
10	$20,801	$83.98	$44,525	$2,587.35	$23.7K → RYLD

AKBLF vs RYLD: Complete Analysis 2026

AKBLF — Stock

ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including house dust mite, grass, tree, ragweed, and Japanese cedar. It also provides adrenaline auto-injectors for the treatment of severe allergic reactions; and manufactures products used in the diagnosis of allergies. The company offers GRAZAX, RAGWITEK, RAGWIZAX, MITICURE, ODACTRA, CEDARCURE, and ITULAZAX for the treatment of allergic rhinitis; and ACARIZAX for treating allergic rhinitis and allergic asthma. ALK-Abelló A/S was founded in 1923 and is headquartered in Hørsholm, Denmark.

Full AKBLF Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this AKBLF vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AKBLF vs SCHD AKBLF vs JEPI AKBLF vs O AKBLF vs KO AKBLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.